nodes	percent_of_prediction	percent_of_DWPC	metapath
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—ID2—ocular cancer	0.119	0.123	CbGpPWpGaD
Gabapentin—BCAT1—Amino acid and derivative metabolism—PSPH—ocular cancer	0.0947	0.0976	CbGpPWpGaD
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—E2F3—ocular cancer	0.0926	0.0953	CbGpPWpGaD
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—CDC25A—ocular cancer	0.0881	0.0907	CbGpPWpGaD
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—CCND2—ocular cancer	0.05	0.0515	CbGpPWpGaD
Gabapentin—CACNA2D2—Regulation of insulin secretion—GNA11—ocular cancer	0.0369	0.038	CbGpPWpGaD
Gabapentin—CACNA2D2—Regulation of insulin secretion—GNAQ—ocular cancer	0.0343	0.0353	CbGpPWpGaD
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—CDK4—ocular cancer	0.0335	0.0345	CbGpPWpGaD
Gabapentin—CACNA1B—Calcium Regulation in the Cardiac Cell—GNA11—ocular cancer	0.0328	0.0338	CbGpPWpGaD
Gabapentin—CACNA1B—Calcium Regulation in the Cardiac Cell—GNAQ—ocular cancer	0.0305	0.0314	CbGpPWpGaD
Gabapentin—CACNA2D2—Integration of energy metabolism—GNA11—ocular cancer	0.029	0.0299	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—CRTC1—ocular cancer	0.0272	0.028	CbGpPWpGaD
Gabapentin—CACNA2D2—Integration of energy metabolism—GNAQ—ocular cancer	0.027	0.0278	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—ID2—ocular cancer	0.0242	0.025	CbGpPWpGaD
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—EP300—ocular cancer	0.0199	0.0205	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PSPH—ocular cancer	0.0174	0.0179	CbGpPWpGaD
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—MYC—ocular cancer	0.0174	0.0179	CbGpPWpGaD
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—TP53—ocular cancer	0.0143	0.0147	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—GNA11—ocular cancer	0.0122	0.0125	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—GNAQ—ocular cancer	0.0113	0.0116	CbGpPWpGaD
Gabapentin—CACNA1B—Transmission across Chemical Synapses—MDM2—ocular cancer	0.0108	0.0111	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PSPH—ocular cancer	0.0105	0.0109	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—HDAC1—ocular cancer	0.0102	0.0105	CbGpPWpGaD
Gabapentin—CACNA1B—Neuronal System—MDM2—ocular cancer	0.00829	0.00853	CbGpPWpGaD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—MDM2—ocular cancer	0.00716	0.00738	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—CDK4—ocular cancer	0.00683	0.00703	CbGpPWpGaD
Gabapentin—CACNA1B—Transmission across Chemical Synapses—HRAS—ocular cancer	0.00593	0.00611	CbGpPWpGaD
Gabapentin—CACNA2D2—Neuronal System—MDM2—ocular cancer	0.00549	0.00565	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—GNA11—ocular cancer	0.00547	0.00564	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—GNAQ—ocular cancer	0.00509	0.00524	CbGpPWpGaD
Gabapentin—Muscle contracture—Dactinomycin—ocular cancer	0.00458	0.158	CcSEcCtD
Gabapentin—CACNA1B—Neuronal System—HRAS—ocular cancer	0.00455	0.00468	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—SAG—ocular cancer	0.00414	0.00427	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—EP300—ocular cancer	0.00406	0.00418	CbGpPWpGaD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—HRAS—ocular cancer	0.00393	0.00405	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—GNA11—ocular cancer	0.00367	0.00378	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—E2F5—ocular cancer	0.00367	0.00378	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—E2F4—ocular cancer	0.00359	0.0037	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—RBL1—ocular cancer	0.00352	0.00363	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—GNAQ—ocular cancer	0.00341	0.00351	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—GNA11—ocular cancer	0.00333	0.00343	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GNA11—ocular cancer	0.00332	0.00342	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—GNAQ—ocular cancer	0.0031	0.00319	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GNAQ—ocular cancer	0.00308	0.00318	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—E2F3—ocular cancer	0.00305	0.00315	CbGpPWpGaD
Gabapentin—CACNA2D2—Neuronal System—HRAS—ocular cancer	0.00301	0.0031	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—TP53—ocular cancer	0.00291	0.00299	CbGpPWpGaD
Gabapentin—Proctitis—Dactinomycin—ocular cancer	0.0029	0.0999	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—TFDP1—ocular cancer	0.00284	0.00292	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MAML2—ocular cancer	0.00226	0.00232	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—GNA11—ocular cancer	0.00197	0.00203	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—GNAQ—ocular cancer	0.00183	0.00188	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—EP300—ocular cancer	0.00183	0.00188	CbGpPWpGaD
Gabapentin—Cheilitis—Dactinomycin—ocular cancer	0.00167	0.0574	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—HDAC1—ocular cancer	0.00165	0.0017	CbGpPWpGaD
Gabapentin—Phlebitis—Carboplatin—ocular cancer	0.00161	0.0554	CcSEcCtD
Gabapentin—Raised liver function tests—Dactinomycin—ocular cancer	0.00153	0.0528	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—CDKN2B—ocular cancer	0.00148	0.00152	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—E2F1—ocular cancer	0.00136	0.0014	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—EP300—ocular cancer	0.00111	0.00114	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—AKT1—ocular cancer	0.00111	0.00114	CbGpPWpGaD
Gabapentin—Hepatomegaly—Dactinomycin—ocular cancer	0.001	0.0345	CcSEcCtD
Gabapentin—Coagulopathy—Dactinomycin—ocular cancer	0.00091	0.0313	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—MDM2—ocular cancer	0.00082	0.000845	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—HRAS—ocular cancer	0.000762	0.000785	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CDKN1B—ocular cancer	0.000749	0.000771	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—AKT1—ocular cancer	0.000741	0.000763	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CCND1—ocular cancer	0.000714	0.000736	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CDKN1A—ocular cancer	0.000691	0.000712	CbGpPWpGaD
Gabapentin—Infection—Carboplatin—ocular cancer	0.000676	0.0233	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—AKT1—ocular cancer	0.000673	0.000693	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—AKT1—ocular cancer	0.00067	0.00069	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—EP300—ocular cancer	0.000658	0.000677	CbGpPWpGaD
Gabapentin—Oesophagitis—Dactinomycin—ocular cancer	0.000647	0.0223	CcSEcCtD
Gabapentin—Mouth ulceration—Dactinomycin—ocular cancer	0.00064	0.0221	CcSEcCtD
Gabapentin—Sepsis—Dactinomycin—ocular cancer	0.000615	0.0212	CcSEcCtD
Gabapentin—Phlebitis—Dactinomycin—ocular cancer	0.000597	0.0206	CcSEcCtD
Gabapentin—Pain—Carboplatin—ocular cancer	0.000582	0.02	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—MYC—ocular cancer	0.000573	0.00059	CbGpPWpGaD
Gabapentin—Hepatic failure—Dactinomycin—ocular cancer	0.000572	0.0197	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—TGFB1—ocular cancer	0.000572	0.000589	CbGpPWpGaD
Gabapentin—Body temperature increased—Carboplatin—ocular cancer	0.000538	0.0185	CcSEcCtD
Gabapentin—Lethargy—Dactinomycin—ocular cancer	0.000525	0.0181	CcSEcCtD
Gabapentin—Liver function test abnormal—Dactinomycin—ocular cancer	0.000475	0.0164	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—TP53—ocular cancer	0.000471	0.000485	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—HRAS—ocular cancer	0.00045	0.000463	CbGpPWpGaD
Gabapentin—Dysphagia—Dactinomycin—ocular cancer	0.000444	0.0153	CcSEcCtD
Gabapentin—Pneumonia—Dactinomycin—ocular cancer	0.000399	0.0137	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—AKT1—ocular cancer	0.000397	0.000409	CbGpPWpGaD
Gabapentin—Stevens-Johnson syndrome—Dactinomycin—ocular cancer	0.000393	0.0135	CcSEcCtD
Gabapentin—Stomatitis—Dactinomycin—ocular cancer	0.000386	0.0133	CcSEcCtD
Gabapentin—Hepatitis—Dactinomycin—ocular cancer	0.000356	0.0123	CcSEcCtD
Gabapentin—Pharyngitis—Dactinomycin—ocular cancer	0.000353	0.0122	CcSEcCtD
Gabapentin—Erythema multiforme—Dactinomycin—ocular cancer	0.000336	0.0116	CcSEcCtD
Gabapentin—Chills—Dactinomycin—ocular cancer	0.000319	0.011	CcSEcCtD
Gabapentin—Alopecia—Dactinomycin—ocular cancer	0.000314	0.0108	CcSEcCtD
Gabapentin—Erythema—Dactinomycin—ocular cancer	0.00031	0.0107	CcSEcCtD
Gabapentin—Ill-defined disorder—Dactinomycin—ocular cancer	0.000287	0.0099	CcSEcCtD
Gabapentin—Anaemia—Dactinomycin—ocular cancer	0.000286	0.00986	CcSEcCtD
Gabapentin—Malaise—Dactinomycin—ocular cancer	0.000279	0.00962	CcSEcCtD
Gabapentin—Leukopenia—Dactinomycin—ocular cancer	0.000277	0.00955	CcSEcCtD
Gabapentin—Myalgia—Dactinomycin—ocular cancer	0.000264	0.00908	CcSEcCtD
Gabapentin—Discomfort—Dactinomycin—ocular cancer	0.00026	0.00897	CcSEcCtD
Gabapentin—Oedema—Dactinomycin—ocular cancer	0.000253	0.0087	CcSEcCtD
Gabapentin—Infection—Dactinomycin—ocular cancer	0.000251	0.00865	CcSEcCtD
Gabapentin—Thrombocytopenia—Dactinomycin—ocular cancer	0.000247	0.00852	CcSEcCtD
Gabapentin—Anorexia—Dactinomycin—ocular cancer	0.000241	0.0083	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Dactinomycin—ocular cancer	0.00023	0.00793	CcSEcCtD
Gabapentin—Decreased appetite—Dactinomycin—ocular cancer	0.00022	0.00757	CcSEcCtD
Gabapentin—Fatigue—Dactinomycin—ocular cancer	0.000218	0.0075	CcSEcCtD
Gabapentin—Pain—Dactinomycin—ocular cancer	0.000216	0.00744	CcSEcCtD
Gabapentin—Feeling abnormal—Dactinomycin—ocular cancer	0.000208	0.00717	CcSEcCtD
Gabapentin—Gastrointestinal pain—Dactinomycin—ocular cancer	0.000207	0.00712	CcSEcCtD
Gabapentin—Body temperature increased—Dactinomycin—ocular cancer	0.0002	0.00688	CcSEcCtD
Gabapentin—Abdominal pain—Dactinomycin—ocular cancer	0.0002	0.00688	CcSEcCtD
Gabapentin—Hypersensitivity—Dactinomycin—ocular cancer	0.000186	0.00641	CcSEcCtD
Gabapentin—Asthenia—Dactinomycin—ocular cancer	0.000181	0.00625	CcSEcCtD
Gabapentin—Diarrhoea—Dactinomycin—ocular cancer	0.000173	0.00596	CcSEcCtD
Gabapentin—Vomiting—Dactinomycin—ocular cancer	0.000161	0.00553	CcSEcCtD
Gabapentin—Rash—Dactinomycin—ocular cancer	0.000159	0.00549	CcSEcCtD
Gabapentin—Nausea—Dactinomycin—ocular cancer	0.00015	0.00517	CcSEcCtD
